Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01169428 · ClinicalTrials.gov registry record · Phase 2
Engaging Motivation for the Prevention of Weight Regain
A Phase 2 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 2
- Development phase
- 95
- Enrollment target
NCT01169428: Completed Phase 2 study, sponsored by Duke University.
NCT01169428 is a Phase 2 study that has completed, run by Duke University. The registered enrollment target is 95 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (29% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01169428, a Phase 2 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 95 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a 12 week Mindfulness-Based Weight Loss Maintenance (MBWLM) intervention is effective in maintaining recent loss of 10% or more of initial body weight.
Primary Outcome
Our primary endpoint will be an evaluation of differential weight loss maintenance (WLM) or weight regain between the two conditions. All weight measures will be taken on the Tanita scale in a standardized fashion, in the morning following a 12 hour fast, after voiding and in bare feet while wearing a standardized outfit.
Interventions
- BEHAVIORAL Mindfulness Based Weight Loss Maintenance (MBWLM)
- BEHAVIORAL Behavioral: Standard Behavioral Weight-Loss Maintenence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2007-07 |
| Est. Completion | 2010-06 |
| Phase | Phase 2 |
What the finished NCT01169428 record still lists
NCT01169428 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (29% lower).
The record links to 0 conditions, and to 2 interventions - of which Mindfulness Based Weight Loss Maintenance (MBWLM) is the first listed.
NCT01169428 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01169428 about?
NCT01169428 is a clinical study titled "Engaging Motivation for the Prevention of Weight Regain". The purpose of this study is to determine whether a 12 week Mindfulness-Based Weight Loss Maintenance (MBWLM) intervention is effective in maintaining recent loss of 10% or more of initial body weight.
What is the current status of trial NCT01169428?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 95 participants. The study started on 2007-07. Estimated completion is 2010-06.
What interventions are being tested in trial NCT01169428?
The interventions under investigation include: Mindfulness Based Weight Loss Maintenance (MBWLM) (BEHAVIORAL), Behavioral: Standard Behavioral Weight-Loss Maintenence (BEHAVIORAL).
Who is sponsoring clinical trial NCT01169428?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01169428's enrollment target sits among peer trials
95 759th of 2000 higher than 1,237 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03339128 · 95 participants · Phase 2
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
- NCT03509961 · 95 participants · Phase 2
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- NCT03694756 · 95 participants · NA
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer
- NCT04206215 · 95 participants · NA
Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia